Panacea Biotec Statistics

Total Valuation

Panacea Biotec has a market cap or net worth of INR 21.44 billion. The enterprise value is 20.78 billion.

Market Cap	21.44B
Enterprise Value	20.78B

Important Dates

The last earnings date was Wednesday, February 11, 2026.

Earnings Date	Feb 11, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	61.25M
Shares Outstanding	n/a
Shares Change (YoY)	+4.44%
Shares Change (QoQ)	-0.15%
Owned by Insiders (%)	68.70%
Owned by Institutions (%)	0.13%
Float	15.42M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.54
PB Ratio	2.61
P/TBV Ratio	2.75
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-267.06
EV / Sales	3.43
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-12.16

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-7.89%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	2.82M
Profits Per Employee	-36,203
Employee Count	2,149
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Panacea Biotec has paid 19.91 million in taxes.

Income Tax	19.91M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.55% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-2.55%
50-Day Moving Average	368.92
200-Day Moving Average	417.78
Relative Strength Index (RSI)	42.01
Average Volume (20 Days)	7,503

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Panacea Biotec had revenue of INR 6.06 billion and -77.80 million in losses. Loss per share was -1.28.

Revenue	6.06B
Gross Profit	3.49B
Operating Income	-599.68M
Pretax Income	-61.58M
Net Income	-77.80M
EBITDA	-292.34M
EBIT	-599.68M
Loss Per Share	-1.28

Full Income Statement

Balance Sheet

The company has 848.70 million in cash and 229.00 million in debt, with a net cash position of 619.70 million.

Cash & Cash Equivalents	848.70M
Total Debt	229.00M
Net Cash	619.70M
Net Cash Per Share	n/a
Equity (Book Value)	8.22B
Book Value Per Share	134.77
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 57.70%, with operating and profit margins of -9.90% and -1.28%.

Gross Margin	57.70%
Operating Margin	-9.90%
Pretax Margin	-1.02%
Profit Margin	-1.28%
EBITDA Margin	-4.83%
EBIT Margin	-9.90%
FCF Margin	n/a

Dividends & Yields

Panacea Biotec does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.44%
Shareholder Yield	-4.44%
Earnings Yield	-0.36%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a